Are you Dr. Martin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 27 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4701 Ogletown Stanton Rd
Suite 3400
Newark, DE 19713Phone+1 302-366-1200Fax+1 302-366-1700
Summary
- Dr. Santos Martin, MD is a hematologist in Newark, Delaware. He is currently licensed to practice medicine in Delaware and North Carolina. He is affiliated with ChristianaCare.
Education & Training
- Rochester General HospitalResidency, Internal Medicine, 1972 - 1975
- University of Puerto Rico School of MedicineClass of 1972
Certifications & Licensure
- DE State Medical License 1982 - 2019
- NC State Medical License 1980 - 1984
- American Board of Pathology Blood Banking
Clinical Trials
- Step'n Out: A Multisite Trial of Collaborative Behavioral Management for Drug-Involved Parolees Start of enrollment: 2005 Feb 01
Publications & Presentations
PubMed
- 130 citationsRituximab Extended Schedule or Re-Treatment Trial for Low–Tumor Burden Follicular Lymphoma: Eastern Cooperative Oncology Group Protocol E4402Brad S. Kahl, Fangxin Hong, Michael E. Williams, Randy D. Gascoyne, Lynne I. Wagner
Journal of Clinical Oncology. 2014-10-01 - 138 citationsA Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtypeWyndham H. Wilson, Sin-Ho Jung, Pierluigi Porcu, David D. Hurd, Jeffrey L. Johnson
Haematologica. 2012-05-01 - 45 citationsA phase 2 trial of extended induction epratuzumab and rituximab for previously untreated follicular lymphoma: CALGB 50701Barbara Grant, Sin-Ho Jung, Jeffrey L. Johnson, Lale Kostakoglu, Eric D. Hsi
Cancer. 2013-11-01